Enteral Feeding Formulas Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

The enteral feeding formulas market is expected to grow from US$ 7,803.45 million in 2021 to US$ 11,726.37 million by 2031 at a CAGR of 6.0% between 2022 and 2031.

Crohn’s disease, gastrointestinal disease due to trauma, bowel obstruction (BO), microscopic colitis, short bowel syndrome, and ulcerative colitis are a few gastrointestinal diseases. According to the article in Heathline, in 2021, around 40% of people across the world were affected by functional gastrointestinal disorder. According to Medscape, in developed countries, the most common cause of small-bowel obstruction (SBO) is intra-abdominal adhesions, accounting for ~65 to 75% of cases, followed by hernias. In contrast, in developing countries, SBO is primarily caused by hernias (30–40%), adhesions (about 30%), and tuberculosis (about 10%). According to the article published by World Journal of Emergency Surgery, bowel obstruction is an important cause of morbidity and mortality accounting for nearly 30,000 deaths and more than US$3 billion per year in direct medical costs. Bowel obstruction is responsible for ~15% of hospital admissions for acute abdominal pain in the US, and ~ 20% of cases need acute surgical care.

Crohn’s disease is a complex, long-lasting (chronic) disorder that primarily affects the digestive system. It is most common disease in North America and Western Europe and has a prevalence of 100 to 300 per 100,000 in these regions. According to Medline Plus, more than half a million in North American and Western European people are currently suffering from Crohn’s disease. Patients suffering from gastrointestinal disease are at an increased risk of nutritional deterioration due to fasting for the diagnostic tests, therapeutic dietary restriction, and appetite loss due to anorexia or altered nutritional requirement. Gastrointestinal disease patients cannot consume food orally. Therefore, enteral route is preferred to provide the required nutrients. A few brands that caters to gastroenterology disorders are Ensure, Ensure HN, Ensure Powder, Isocal, Lonalac Powder, Meritene, Meritene Powder, Osmolite, Osmolite HN, Portagen Powder, Sustacal, Sustagen Powder, and Travasorb.  Therefore, the growing prevalence of gastrointestinal diseases drives the growth of the enteral feeding formulas market

MARKET DYNAMICS

The growth of the enteral feeding formulas market is majorly attributed to the rising prevalence of gastrointestinal disorders and the increasing prevalence of cachexia. However, mechanical or enteral tube-related problems hamper the growth of the market. The usage of next-generation technology for proper enteral nutrition feeding is projected to offer lucrative opportunities for the growth of the enteral feeding formulas market during the forecast period.

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Get FREE CUSTOMIZATION

Enteral Feeding Formulas Market: Strategic Insights

• Get Top Key Market Trends of this report.
  This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Free Sample PDF

MARKET SCOPE

The "Global Enteral Feeding Formulas Market Analysis to 2031"  report aims to provide an overview of enteral feeding formulas market with detailed market segmentation based on type, application, form, age group, and distribution channel. The report provides key statistics based on the financial performances of the leading enteral feeding formulas market players. It also offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global enteral feeding formulas market is segmented on the basis of type, application, form, age group, and distribution channel. Based on type, the market is segmented into standard formulas, peptide formulas, specialized formulas, and others. By application, the market is segmented into respiratory disorders, cancer, gastroenterology disorders, diabetes, liver/kidney disease, neurology, post COVID-19, and others. Based on form, the enteral feeding formulas market is segmented into powder, liquid, and semi-solid. Based on age group, the market is bifurcated into adult (18+ years) and children (till 18 years). In terms of distribution channel, the market is segmented into hospital pharmacies, retail stores, and others.

REGIONAL FRAMEWORK

The global enteral feeding formulas market is segmented into five major regions—North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. The report covers analysis and forecast of 18 countries globally along with trends and opportunities prevailing in the regions.

North America dominated the enteral feeding formulas market capturing more than 41% market share in 2021. The market growth in North America is driven by the growing prevalence of gastroenterology disorders in the US.  According to Centers for Disease Control and prevention, the number of adults with diagnosed ulcers in the United States was 14.8 million in 2021. The number of visits to emergency departments with diseases of the digestive system as the primary diagnosis was 7.9 million in 2021 in the United States. As a result, the enteral feeding formulas acts as a medium to overcome or prevent such illnesses owing to the source of nutrients (protein, carbohydrates, etc.) received from the enteral feeding formula products.

 The below figure shows the revenue growth trend in the enteral feeding formulas market:

The report analyzes factors, such as drivers, restraints, opportunities, and future trends, which impact the growth of the enteral feeding formulas market. It also provides exhaustive Porter's five forces analysis of the factors influencing the market.

IMPACT OF COVID-19 PANDEMIC

According to a research article published in Critical Care, 2021, the novel coronavirus may invade the gastrointestinal tract, neurological systems, and kidneys, which may adversely affect the nutrition delivery among COVID-19 patients. As per the guidelines by the European Society for Clinical Nutrition and Metabolism (ESPEN) on nutrition in the ICU, gastric/renal enteral formulas are recommended for severe COVID-19 patients admitted in the intensive care units (ICUs). Hence, the demand for enteral feeding formulas increased globally due to the rising number of COVID-19 patients, especially in ICUs.

MARKET PLAYERS

The report covers key developments in the enteral feeding formulas market. Various companies are focusing on organic growth strategies, such as product launches, product approvals, and patents and events. In addition, acquisitions, and partnership & collaborations are among the inorganic growth strategies witnessed in the market. These activities have paved way for the expansion of business and customer base of market players. The players operating in the enteral feeding formulas market are anticipated to experience lucrative growth opportunities in the future owing to the rising demand for enteral feeding formulas.

The report also includes the profiles of key enteral feeding formulas market companies along with their SWOT analysis and market strategies. In addition, it focuses on leading industry players with information, such as company profiles, components and services offered, financial information of last 3 years, and key development in past five years.

Below mentioned is the list of a few companies engaged in the enteral feeding formulas market.

• Abbott
• Nestle Health Science
• Magnacal Renal
• UNILEVER
• Danone
• Kate Farms
• Nutricia
• Smartfish AS
• Fresenius Kabi AG
• Hormel Foods Corporation

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Report Scope

Enteral Feeding Formulas Market Regional Insights

The regional trends and factors influencing the Enteral Feeding Formulas Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Enteral Feeding Formulas Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Enteral Feeding Formulas Market Report Scope

Enteral Feeding Formulas Market Players Density: Understanding Its Impact on Business Dynamics

The Enteral Feeding Formulas Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

Major Companies operating in the Enteral Feeding Formulas Market are:

1. Abbott
2. B. Braun Melsungen AG
3. Danone
4. Fresenius Kabi India Pvt. Ltd
5. Global Health Products, Inc.

Disclaimer: The companies listed above are not ranked in any particular order.